Track Krsnaa Diagnostics Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -2.66 %
Low
532.1
High
575.5
1 Month returns: 1.93 %
Low
520.8
High
586.6
1 Year returns: -30.75 %
Low
502.2
High
894.4
3 Year CAGR: -0.86 %
Low
502.2
High
1,044.0
5 Year CAGR: -9.55 %
Low
353.1
High
1,044.0
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Krsnaa Diagnostics Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Krsnaa Diagnostics Ltd. Shareholding Pattern
Quarterly breakdown of Krsnaa Diagnostics Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Krsnaa Diagnostics Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Krsnaa Diagnostics Ltd.?
The current share price of Krsnaa Diagnostics Ltd. is ₹ 560.00 as of 21 Aug 2026.
What is the market capitalisation of Krsnaa Diagnostics Ltd.?
The market capitalisation of Krsnaa Diagnostics Ltd. stands at ₹ 1,816.58 Cr.
What is the PE ratio of Krsnaa Diagnostics Ltd.?
The Price-to-Earnings (PE) ratio of Krsnaa Diagnostics Ltd. is 18.64 as of the latest trailing twelve months data.
What is the ROE and ROCE of Krsnaa Diagnostics Ltd.?
Krsnaa Diagnostics Ltd. has a Return on Equity (ROE) of 10.89% and a Return on Capital Employed (ROCE) of 9.34% as per the latest financial reports.
What is the 52-week high and low of Krsnaa Diagnostics Ltd.?
The 52-week high of Krsnaa Diagnostics Ltd. is - and the 52-week low is -.
What is the dividend yield of Krsnaa Diagnostics Ltd.?
The dividend yield of Krsnaa Diagnostics Ltd. is 0.36% based on the current market price.
What is the FII and DII holding in Krsnaa Diagnostics Ltd.?
Foreign Institutional Investors (FII) hold 4.28%, Domestic Institutional Investors (DII) hold 12.84% and retail/public investors hold 32.26% of Krsnaa Diagnostics Ltd. shares.
What sector does Krsnaa Diagnostics Ltd. belong to?
Krsnaa Diagnostics Ltd. operates in the Healthcare sector. 66.67% of analysts have a Buy or Strong Buy rating on Krsnaa Diagnostics Ltd. with a consensus target price of ₹ 798.00, implying 42.5% upside from current levels.
What is the beta of Krsnaa Diagnostics Ltd.?
The beta of Krsnaa Diagnostics Ltd. is 0.87, indicating its price volatility relative to the broader market. Over the past 1 year, Krsnaa Diagnostics Ltd. has delivered an absolute return of -29.83%.
What is the RSI of Krsnaa Diagnostics Ltd.?
The 14-day Relative Strength Index (RSI) of Krsnaa Diagnostics Ltd. is 52.98, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Corporate Actions
History of Krsnaa Diagnostics Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.
Dividend₹ 2/share
Record date: 18th Sep 2026Ex-date: 18th Sep 2026
Announced on: 25th May 2026
Dividend₹ 2.75/share
Record date: 12th Sep 2025Ex-date: 12th Sep 2025
Announced on: 12th May 2025
Dividend₹ 2.50/share
Record date: 13th Sep 2024Ex-date: 13th Sep 2024
Announced on: 19th May 2024
Dividend₹ 2.75/share
Record date: 15th Sep 2023Ex-date: 15th Sep 2023
Announced on: 27th May 2023
Dividend₹ 2.50/share
Record date: 16th Sep 2022Ex-date: 15th Sep 2022
Announced on: 30th May 2022
Stock Analysis
Fundamental analysis overview of Krsnaa Diagnostics Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
PE TTM of 18.64 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -14.02%
What is P/E Ratio?
Median: 21.68
Value 18.64
5.33378.26
Moderate ROE but improving trend
The company reported moderate ROE of 10.89% for 12-month ended 30 Jun 2026 but ROE improved by 172 bps from 1 year ago
What is ROE (FY)?
High and stable operating margin
The company reported strong operating margin of 15.71% for 12-month ended 30 Jun 2026 and operating margin improved marginally by 79 bps from 1 year ago
What is Operating profit margin?
Strong EPS growth and in line with median growth of industry
The company delivered strong EPS growth of 21.78% for 12-month ended 30 Jun 2026 and the growth was 0.3 percentage points higher than median growth of industry
What is EPS growth (1Y)?
Consistently pays dividend
The company has not missed dividend payments once in the last 4 financial years
What is Dividend streak?
Negative
Weak price momentum
Price Momentum score of 15.3 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term
What is Price Momentum score?
15.3 / 100
Analysts have been downgrading forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has decreased by -17.0% in the last 3 months, indicating weak earnings momentum
What is Earnings upgrade (3M)?
Moderate revenue growth but lower than median growth of industry
The company delivered moderate revenue growth of 10.19% for 12-month ended 30 Jun 2026 but the growth was 4.38 percentage points lower than median growth of industry
What is Sales growth (1Y)?
Median: 14.57
Value 10.19
-93.87133.74
Low dividend yield
The company has a low dividend yield of 0.36%
What is Dividend yield?
Neutral
Low Debt to Equity but increasing
The company has low Debt to Equity of 0.55 as on 30 Jun 2026 but Debt to Equity increased by 0.32 in the last 1 year
What is Debt to Equity?
Company's earnings are of moderate quality
Earnings quality score of 46.8 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
46.8 / 100
No red flags found!
No significant red flags found in the stock.
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Promoter
27.38
27.38
27.38
27.38
27.80
27.80
27.80
27.80
27.80
27.03
27.03
27.17
27.17
27.24
27.24
27.11
27.11
27.11
27.11
27.11
Indian Promoter
27.38
27.38
27.38
27.38
27.80
27.80
27.80
27.80
27.80
27.03
27.03
27.17
27.17
27.24
27.24
27.11
27.11
27.11
27.11
27.11
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
36.16
34.58
33.13
31.63
24.49
23.55
21.87
25.46
22.41
20.02
18.71
18.59
19.49
18.50
17.81
17.64
18.63
18.03
17.80
18.79
Mutual Funds / UTI
9.61
11.22
10.56
10.46
10.99
11.58
12.00
13.26
13.99
11.89
11.05
11.91
11.56
9.82
9.36
9.63
10.46
10.15
10.17
10.17
FI/Bank/Insurance
0.03
0.00
0.00
0.01
9.43
7.83
6.49
6.51
4.66
4.46
4.09
2.86
2.86
2.95
2.95
2.69
2.67
2.67
2.67
2.67
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
6.00
10.82
4.49
4.27
4.06
4.14
3.38
5.69
3.68
3.44
3.34
3.33
3.63
4.04
3.55
3.40
3.66
4.17
3.91
4.28
Other Institutions
20.52
12.54
35.95
33.76
0.01
0.00
0.01
0.00
0.08
0.24
0.23
0.49
1.44
1.69
1.95
1.92
1.83
1.03
1.05
1.67
Non-Institution
36.45
38.04
39.49
40.98
47.72
48.66
50.33
46.74
49.79
52.95
54.26
54.24
53.34
54.27
54.94
55.25
54.26
54.85
55.08
54.09
Bodies Corporate
18.81
18.88
19.25
19.52
20.23
19.66
19.98
19.97
20.80
20.52
21.65
21.67
21.05
21.03
21.53
21.80
22.28
22.43
21.93
21.83
Others (incl. Retail)
No. of shareholders
17.64
75,304
19.16
74,820
20.24
71,234
21.46
70,040
27.49
69,797
29.00
68,439
30.35
66,859
26.77
61,998
28.99
60,389
32.43
56,913
32.61
56,129
32.57
55,604
32.29
53,178
33.24
52,405
33.41
53,034
33.45
53,731
31.98
51,557
32.42
51,788
33.15
52,451
32.26
53,081
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Name
Month
Transaction
Holding % pre transaction
Average price
Qty.
Transaction value
Krsna Diagnostics Mumbai Private Limited
Promoter Group
December-2024
Market Purchase (Acquisition)
31st Dec 2024
2.30 %
₹ 870.89
22.93 k
₹ 2.00 cr
KRSNA DIAGNOSTICS MUMBAI PRIVATE LIMITED
Promoter Group
June-2024
Market Purchase (Acquisition)
6th Jun 2024
2.16 %
₹ 540.86
45.00 k
₹ 2.43 cr
Phi Capital Trust – Phi Capital Growth Fund – 1
Connected Person
February-2022
Market Purchase (Acquisition)
21st Feb 2022
15.82 %
₹ 604.94
10.00 k
₹ 60.49 lac
Phi Capital Trust – Phi Capital Growth Fund – 1
Connected Person
February-2022
Market Purchase (Acquisition)
21st Feb 2022
15.85 %
₹ 603.25
7.70 k
₹ 46.45 lac
Phi Capital Trust – Phi Capital Growth Fund – 1
Connected Person
February-2022
Market Purchase (Acquisition)
18th Feb 2022
15.77 %
₹ 619.92
5.29 k
₹ 32.78 lac
Phi Capital Trust – Phi Capital Growth Fund – 1
Connected Person
February-2022
Market Purchase (Acquisition)
18th Feb 2022
15.79 %
₹ 615.16
10.00 k
₹ 61.52 lac
Phi Capital Trust – Phi Capital Growth Fund – 1
Connected Person
February-2022
Market Purchase (Acquisition)
16th Feb 2022
15.67 %
₹ 643.43
7.16 k
₹ 46.06 lac
Phi Capital Trust – Phi Capital Growth Fund – 1
Connected Person
February-2022
Market Purchase (Acquisition)
16th Feb 2022
15.69 %
₹ 640.73
25.00 k
₹ 1.60 cr
Phi Capital Trust – Phi Capital Growth Fund – 1
Connected Person
February-2022
Market Purchase (Acquisition)
10th Feb 2022
15.50 %
₹ 652.09
1.78 k
₹ 11.61 lac
Phi Capital Trust – Phi Capital Growth Fund – 1
Connected Person
February-2022
Market Purchase (Acquisition)
10th Feb 2022
15.51 %
₹ 658.80
50.00 k
₹ 3.29 cr
Company Profile
Overview of Krsnaa Diagnostics Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Krsnaa Diagnostics Limited is engaged in the business of providing diagnostic services primarily in relation to pathology investigation, radiology investigation, and tele reporting. The Company’s services include pathology, X-Ray and computed tomography (CT) scans, magnetic resonance imaging (MRI), ultrasonography (USG), tele-radiology, tele-pathology, and other diagnostic services. Its laboratory services span a diverse range of investigations, ranging from CBC or blood glucose to highly specialized tests. Its tele-radiology services enable radiologists to offer treatment remotely. Tele-radiology involves transmitting radiological images, such as CT scans, digitized X-rays, MRIs, and ultrasounds between different locations. It offers Ayaksham package, which includes from basic to total plus health checkups. It provides diagnostic testing packages for diabetes, heart health, liver health, kidney health, thyroid, fatigue, cancer, senior citizen care, bone health, and others.
Krsnaa Diagnostics Limited is engaged in the business of providing diagnostic services primarily in relation to pathology investigation, radiology investigation, and tele reporting. The Company’s services include pathology, X-Ray and computed tomography (CT) scans, magnetic resonance imaging (MRI), ...